Aster DM Healthcare Limited

NSE ASTERDM.NS

Aster DM Healthcare Limited Revenue for the year ending March 31, 2024: USD 443.46 M

Aster DM Healthcare Limited Revenue is USD 443.46 M for the year ending March 31, 2024, a -69.46% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Aster DM Healthcare Limited Revenue for the year ending March 31, 2023 was USD 1.45 B, a 7.52% change year over year.
  • Aster DM Healthcare Limited Revenue for the year ending March 31, 2022 was USD 1.35 B, a 14.86% change year over year.
  • Aster DM Healthcare Limited Revenue for the year ending March 31, 2021 was USD 1.18 B, a 1.38% change year over year.
  • Aster DM Healthcare Limited Revenue for the year ending March 31, 2020 was USD 1.16 B, a 1.20% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NSE: ASTERDM.NS

Aster DM Healthcare Limited

CEO Ms. Alisha Moopen
IPO Date Feb. 26, 2018
Location United Arab Emirates
Headquarters Tower D - Aspect Tower
Employees 14,016
Sector Health Care
Industries
Description

Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company operates through Hospitals, Clinics, Retail Pharmacies, and Other segments. It provides primary, secondary, tertiary, and quaternary healthcare services through 29 hospitals, 120 clinics, 371 retail pharmacies, 114 labs, and patient experience centers under the Aster, Medcare, and Access brands. In addition, it offers healthcare retailing, diagnostic laboratories, digital health, and medical education services. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates.

Similar companies

NH.NS

Narayana Hrudayalaya Limited

USD 14.93

1.77%

SIS.NS

SIS Limited

USD 3.82

-1.87%

BDL.NS

Bharat Dynamics Limited

USD 13.31

3.38%

ERIS.NS

Eris Lifesciences Limited

USD 14.77

2.53%

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.54

0.38%

StockViz Staff

January 15, 2025

Any question? Send us an email